Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
29.72
1.84 (6.60%)
At close: Oct 03, 2025, 3:59 PM
29.90
0.61%
After-hours: Oct 03, 2025, 07:58 PM EDT
6.60% (1D)
| Bid | 27.93 |
| Market Cap | 3.34B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -171.55M |
| EPS (ttm) | -1.54 |
| PE Ratio (ttm) | -19.3 |
| Forward PE | -8.91 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 30.9 |
| Volume | 5,274,548 |
| Avg. Volume (20D) | 6,242,369 |
| Open | 28.23 |
| Previous Close | 27.88 |
| Day's Range | 28.09 - 29.85 |
| 52-Week Range | 18.92 - 81.73 |
| Beta | 0.64 |
| Ex-Dividend Date | n/a |
About VKTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VKTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-42.12%
Viking Therapeutics shares are trading lower follo...
Unlock content with
Pro Subscription
1 month ago
-42.12%
VKTX stock has given up its prior gain. Viking Therapeutics shares were trading higher after the company's obesity drug showed up to 12% weight loss in a Phase 2 trial.
